BRIEF-Janssen Inc says Health Canada issued notice of compliance with conditions approving Darzalex
June 30 (Reuters) - Johnson & Johnson
* Janssen Inc says Health Canada has issued a notice of compliance with conditions approving Darzalex
* Janssen Inc says Darzalex approved by Health Canada for for treatment of multiple Myeloma
* Janssen Inc says product approved on condition that co carries out confirmatory trials to verify clinical benefit of Darzalex Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)
© Thomson Reuters 2017 All rights reserved.